BENUVIA OPERATIONS, LLC

Benuvia Operations, LLC specializes in the synthesis of bulk drug substances under current Good Manufacturing Practices (cGMP), with demonstrated expertise in the production of controlled psychoactive compounds for research and therapeutic development. Their technical capabilities center on organic synthesis, process development, and quality-controlled manufacturing of complex pharmaceutical intermediates, particularly in the context of psychedelic therapeutics. The company applies rigorous analytical validation, impurity profiling, and batch documentation protocols to ensure compliance with FDA and DEA regulatory frameworks, positioning them as a niche provider of GMP-grade materials for early-stage clinical research. Their work in psilocybin synthesis reflects deep proficiency in stereochemical control, solvent recovery systems, and closed-loop reaction engineering under controlled environmental conditions. Benuvia has delivered specialized research and development services to the Department of Health and Human Services, specifically supporting initiatives in neuropsychopharmacology and novel psychotherapeutic agent development. Their engagement with HHS indicates a focused partnership in advancing non-traditional therapeutic modalities, likely supporting agencies such as NIDA or NIH institutes focused on mental health innovation. The contractor’s primary industry focus is Research and Development in the Physical, Engineering, and Life Sciences, excluding nanotechnology and biotechnology. This translates to applied chemistry and process-scale manufacturing for bioactive molecules, with a clear specialization in the emerging field of psychedelic medicine. They occupy a unique position in the federal R&D ecosystem as a small-scale, high-purity synthesis provider for investigational new drugs. Benuvia Operations, LLC is a small business structured as a 2K entity, headquartered in Round Rock, Texas. While currently holding no formal government certifications, their operational rigor in GMP synthesis and regulatory compliance enables them to serve sensitive federal research programs. Their geographic presence in Texas supports access to state-level biotech infrastructure and a growing life sciences talent pool, reinforcing their role as a specialized contractor in the federal pharmaceutical innovation supply chain.